COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

2 Killed in Crash on Interstate 880 Near Davis Street


Car Engulfed in Flames in Fatal San Leandro Accident

San Leandro, CA (July 11, 2020) – Two men were killed in a crash in solo-vehicle crash in San Leandro. The fatal accident occurred on the morning of July 11 on Interstate 880. 

A vehicle crashed on southbound Interstate 880, near the Davis Street offramp. It became engulfed in flames. There were two men inside the vehicle, estimated to be in their 20s or 30s. One was ejected from the vehicle, while the other was inside the burning car. Both died at the accident scene.


Our heartfelt condolences go out to the friends and loved ones of the victims.

#San Leandro

#94577


July 22, 2020

Crash on State Route 299 Causes Major Injuries

Vehicle Overturns in Redding Accident...


May 12, 2020

2 Injured in Crash on Old Oregon Trail

2 Vehicles Collide Head-on in Redding Accident...


August 6, 2020

1 Killed in Crash at Highway 163 and Genesee Avenue

Big Rig, Pickup Truck Collide in Fatal San Diego Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.